United States Gene Therapy Sales Market by Manufacturers, Type and Application, Forecast to 2021

United States Gene Therapy Sales Market by Manufacturers, Type and Application, Forecast to 2021

  • United States Gene Therapy Sales Market by Manufacturers, Type and Application, Forecast to 2021

    Gene therapy is an experimental treatment that involves introducing genetic material into a person s cells to fight or prevent disease. Researchers are studying gene therapy f

    • Release Date: October 04, 2016
    • Price: USD 4480
    • Format: Pdf

    Select Quantity and Version

    Select an Option & Purchase




           

Gene therapy is an experimental treatment that involves introducing genetic material into a person s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a  vector. The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy. Scope of the Report: This report focuses on the Gene Therapy Sales in United States market. This report categorizes the market based on manufacturers, type and application. Market Segment by Manufacturers, this report covers Bluebird Bio Sangamo Spark Therapeutics Dimension Therapeutics Avalanche Bio Celladon Vical Inc. Advantagene Market Segment by Type, covers Ex Vivo In Vivo Market Segment by Applications, can be divided into Cancer Diseases Monogenic Diseases Infectious Diseases Cardiovascular Diseases Other There are 11 Chapters to deeply display the United States Gene Therapy Sales market. Chapter 1, to describe Gene Therapy Sales Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Gene Therapy Sales, with sales, revenue, and price of Gene Therapy Sales, in 2015 and 2016; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016; Chapter 4 and 5, to show the market of Gene Therapy Sales by type and application, with sales market share and growth rate by type, application, from 2011 to 2016; Chapter 6, Gene Therapy Sales market forecast, by type and application, with sales and revenue, from 2016 to 2021; Chapter 7, to analyze the Gene Therapy Sales market development potential except United States, covering China, Southeast Asia, India, Latin America etc. Chapter 8, 9, 10 and 11, to describe sales channel, distributors, traders, dealers, market effect factors, appendix and data source.

Table of Contents

United States Gene Therapy Sales Market by Manufacturers, Type and Application, Forecast to 2021
1 Market Overview (Market Segment, Status and Outlook)
1.1 Gene Therapy Sales Introduction
1.2 United States Gene Therapy Sales Market Analysis by Type
1.2.1 Ex Vivo
1.2.2 In Vivo
1.3 United States Gene Therapy Sales Market Analysis by Applications
1.3.1 Cancer Diseases
1.3.2 Monogenic Diseases
1.3.3 Infectious Diseases
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 United States Market Gene Therapy Sales Overview
1.4.1 United States Gene Therapy Sales Development Status and Outlook
1.4.2 Market Opportunities
1.4.3 Market Risk
1.4.4 Market Driving Force
2 Manufacturers Profiles
2.1 Bluebird Bio
2.1.1 Business Overview
2.1.2 Gene Therapy Sales Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.2 Bluebird Bio Gene Therapy Sales Sales, Price, Revenue, Gross Margin and Market Share
2.2 Sangamo
2.2.1 Business Overview
2.2.2 Gene Therapy Sales Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.2 Sangamo Gene Therapy Sales Sales, Price, Revenue, Gross Margin and Market Share
2.3 Spark Therapeutics
2.3.1 Business Overview
2.3.2 Gene Therapy Sales Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.2 Spark Therapeutics Gene Therapy Sales Sales, Price, Revenue, Gross Margin and Market Share
2.4 Dimension Therapeutics
2.4.1 Business Overview
2.4.2 Gene Therapy Sales Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.2 Dimension Therapeutics Gene Therapy Sales Sales, Price, Revenue, Gross Margin and Market Share
2.5 Avalanche Bio
2.5.1 Business Overview
2.5.2 Gene Therapy Sales Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.2 Avalanche Bio Gene Therapy Sales Sales, Price, Revenue, Gross Margin and Market Share
2.6 Celladon
2.6.1 Business Overview
2.6.2 Gene Therapy Sales Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.2 Celladon Gene Therapy Sales Sales, Price, Revenue, Gross Margin and Market Share
2.7 Vical Inc.
2.7.1 Business Overview
2.7.2 Gene Therapy Sales Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.2 Vical Inc. Gene Therapy Sales Sales, Price, Revenue, Gross Margin and Market Share
2.8 Advantagene
2.8.1 Business Overview
2.8.2 Gene Therapy Sales Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.2 Advantagene Gene Therapy Sales Sales, Price, Revenue, Gross Margin and Market Share
3 United States Gene Therapy Sales Market Competition, by Manufacturer
3.1 United States Gene Therapy Sales Sales and Market Share by Manufacturer
3.2 United States Gene Therapy Sales Revenue (Value) and Market Share by Manufacturer
3.3 Market Concentration Rate Analysis
3.3.1 Top 3 Gene Therapy Sales Manufacturer Market Share
3.3.2 Top 6 Gene Therapy Sales Manufacturer Market Share
3.4 Market Competition Trend
4 Gene Therapy Sales Market Segment by Type
4.1 United States Gene Therapy Sales Sales, Revenue and Market Share by Type (2011-2016)
4.1.1 United States Gene Therapy Sales Sales and Market Share by Type (2011-2016)
4.1.2 United States Gene Therapy Sales Revenue and Market Share by Type (2011-2016)
4.2 Ex Vivo Sales Growth and Price
4.2.1 United States Ex Vivo Sales Growth (2011-2016)
4.2.2 United States Ex Vivo Price (2011-2016)
4.3 In Vivo Sales Growth and Price
4.3.1 United States In Vivo Sales Growth (2011-2016)
4.3.2 United States In Vivo Price (2011-2016)
4.4 Sales Growth and Price
4.4.1 United States Sales Growth (2011-2016)
4.4.2 United States Price (2011-2016)
4.5 Sales Growth and Price
4.5.1 United States Sales Growth (2011-2016)
4.5.2 United States Price (2011-2016)
5 United States Gene Therapy Sales Market Segment by Application
5.1 United States Gene Therapy Sales Sales Market Share by Application (2011-2016)
5.2 Cancer Diseases Sales Growth (2011-2016)
5.3 Monogenic Diseases Sales Growth (2011-2016)
5.4 Infectious Diseases Sales Growth (2011-2016)
5.5 Cardiovascular Diseases Sales Growth (2011-2016)
5.6 Other Sales Growth (2011-2016)
5.7 Sales Growth (2011-2016)
6 United States Gene Therapy Sales Market Forecast (2016-2021)
6.1 United States Gene Therapy Sales Sales, Revenue (Value) and Growth Rate (2016-2021)
6.2 Gene Therapy Sales Market Forecast by Type (2016-2021)
6.3 Gene Therapy Sales Market Forecast by Application (2016-2021)
7 Gene Therapy Sales Potential Market/Regions except USA
7.1 China Development Status and Outlook
7.1.1 China Gene Therapy Sales Sales, Growth Rate and Forecast (2016-2021)
7.1.2 China Gene Therapy Sales Revenue (Value), Growth Rate and Forecast (2016-2021)
7.2 Southeast Asia Development Status and Outlook
7.2.1 Southeast Asia Gene Therapy Sales Sales, Growth Rate and Forecast (2016-2021)
7.2.2 Southeast Asia Gene Therapy Sales Revenue (Value), Growth Rate and Forecast (2016-2021)
7.3 India Development Status and Outlook
7.3.1 India Gene Therapy Sales Sales, Growth Rate and Forecast (2016-2021)
7.3.2 India Gene Therapy Sales Revenue (Value), Growth Rate and Forecast (2016-2021)
7.4 Latin America Development Status and Outlook
7.4.1 Latin America Gene Therapy Sales Sales, Growth Rate and Forecast (2016-2021)
7.4.2 Latin America Gene Therapy Sales Revenue (Value), Growth Rate and Forecast (2016-2021)
8 Marketing Strategy Analysis
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
9 Effect Factors of Gene Therapy Sales Demand
9.1 Technology Progress
9.2 Consumer Needs Trend/Customer Preference
9.3 External Environmental Change
9.3.1 Technology Progress of Related Industry
9.3.2 External Economic Environment
10 Sales Channel, Distributors, Traders and Dealers
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Future Trend
10.2 Distributors, Traders and Dealers
11 Appendix
11.1 Methodology
11.2 Analyst Introduction
11.3 Data Source

Send Enquiry


Version :

Single User
Multi User
Enterprise




Can't read the image? click here to refresh


Log In Your Account